Ogasawara Y, McCormack F X, Mason R J, Voelker D R
Lord and Taylor Laboratory for Lung Biochemistry, Department of Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206.
J Biol Chem. 1994 Nov 25;269(47):29785-92.
Pulmonary surfactant proteins A (SP-A) and D (SP-D) possess similar structure as members of the mammalian C-type lectin superfamily. Both proteins are composed of four characteristic domains which are: 1) an NH2-terminal domain involved in interchain disulfide formation (denoted A1 domain for SP-A or D1 for SP-D); 2) a collagenous domain (denoted A2 or D2); 3) a neck domain (denoted A3 or D3); and 4) a carbohydrate recognition domain (denoted A4 or D4). SP-A specifically binds to dipalmitoylphosphatidylcholine, the major lipid component of surfactant, and can regulate the secretion and recycling of this lipid by alveolar type II cells. SP-D binds to phosphatidylinositol (PI) and glucosylceramide (GlcCer), and its role in alveolar lipid metabolism remains to be clarified. To understand the relationship between the structure and the function of both proteins with respect to their interaction with lipids, we expressed recombinant wild type rat SP-D (rSP-D) and chimeric molecules of SP-A and SP-D (A1A2A3D4, A1A2D3D4, and D1D2A3A4) using a baculovirus expression system, and performed lipid binding and aggregation assays. The rSP-D effectively competed with 125I-labeled native rat SP-D in a solid phase binding assay to PI and GlcCer in a manner nearly identical to native SP-D. The rSP-D also bound to PI liposomes with approximately half the affinity of native rat SP-D. Chimera A1A2D3D4 competed with iodinated SP-D in the solid phase binding assay to both PI and GlcCer. This chimera did not bind to dipalmitoylphosphatidylcholine (DPPC) liposomes or induce their aggregation. Chimera A1A2A3D4 did not bind solid phase PI or GlcCer but was equivalent to rSP-D in binding to PI liposomes. This chimera exhibited weak binding to DPPC but failed to aggregate DPPC liposomes. Chimera D1D2A3A4 failed to bind PI and GlcCer and bound weakly to DPPC liposomes but was quite effective at inducing aggregation of DPPC liposomes. These findings demonstrate that the D3 plus D4 domains of SP-D play a role in lipid binding and that the D4 domain is essential for PI binding. Furthermore, the A3 domain of SP-A cannot account for all the lipid binding activity of this protein. In addition, the results implicate the A4 domain of SP-A as an important structural domain in lipid aggregation phenomena.
肺表面活性物质蛋白A(SP-A)和蛋白D(SP-D)作为哺乳动物C型凝集素超家族的成员,具有相似的结构。这两种蛋白均由四个特征性结构域组成,分别为:1)参与链间二硫键形成的NH2末端结构域(SP-A的该结构域称为A1结构域,SP-D的称为D1结构域);2)胶原结构域(称为A2或D2);3)颈部结构域(称为A3或D3);4)碳水化合物识别结构域(称为A4或D4)。SP-A能特异性结合表面活性剂的主要脂质成分二棕榈酰磷脂酰胆碱,并可调节II型肺泡细胞对这种脂质的分泌和再循环。SP-D能结合磷脂酰肌醇(PI)和葡萄糖神经酰胺(GlcCer),其在肺泡脂质代谢中的作用尚待阐明。为了解这两种蛋白在与脂质相互作用方面的结构与功能之间的关系,我们利用杆状病毒表达系统表达了重组野生型大鼠SP-D(rSP-D)以及SP-A和SP-D的嵌合分子(A1A2A3D4、A1A2D3D4和D1D2A3A4),并进行了脂质结合和聚集分析。在固相结合分析中,rSP-D与125I标记的天然大鼠SP-D对PI和GlcCer的结合具有几乎相同的竞争性,其竞争方式与天然SP-D相近。rSP-D与PI脂质体的结合亲和力约为天然大鼠SP-D的一半。嵌合体A1A2D3D4在固相结合分析中与碘化SP-D竞争结合PI和GlcCer。该嵌合体不与二棕榈酰磷脂酰胆碱(DPPC)脂质体结合,也不诱导其聚集。嵌合体A1A2A3D4不结合固相PI或GlcCer,但在结合PI脂质体方面与rSP-D相当。该嵌合体与DPPC的结合较弱,但不能使DPPC脂质体聚集。嵌合体D1D2A3A4不结合PI和GlcCer,与DPPC脂质体的结合较弱,但在诱导DPPC脂质体聚集方面相当有效。这些发现表明,SP-D的D3和D4结构域在脂质结合中起作用,且D4结构域对于PI结合至关重要。此外,SP-A的A3结构域不能解释该蛋白的所有脂质结合活性。此外,结果表明SP-A的A4结构域是脂质聚集现象中的一个重要结构域。